Koers GB Sciences, Inc. Other OTC
Aandelen
GBLX
US3615441090
Biotechnologie & Medisch Onderzoek
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 6,83 mln. 6,29 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | - 0 | Nettowinst (verlies) 2023 | -4 mln. -3,69 mln. | EV/omzet 2022 | - |
Nettoschuld 2022 | 1,15 mln. 1,06 mln. | Nettoschuld 2023 | 1,29 mln. 1,19 mln. | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-16,8
x | K/w-verhouding 2023 |
-1,56
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 87,78% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John Poss
CEO | Chief Executive Officer | 76 | 27-07-15 |
President | 54 | 10-06-14 | |
Monica Poss
PRN | Corporate Officer/Principal | - | 01-09-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
President | 54 | 10-06-14 | |
John Poss
CEO | Chief Executive Officer | 76 | 27-07-15 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+43,36% | 54,63 mld. | |
-5,31% | 39,92 mld. | |
+14,75% | 26,86 mld. | |
-12,56% | 26,22 mld. | |
-22,45% | 18,78 mld. | |
+25,12% | 12,21 mld. | |
+0,04% | 12,16 mld. | |
+26,04% | 11,94 mld. | |
-11,83% | 10,74 mld. |